Embryo transfer associated with hormone replacement therapy cycles using assisted reproductive technology increases placenta accreta spectrum.
Yuya SakaiMasanori OnoTakashi IizukaKyosuke KagamiSakiko MasumotoMidori NakayamaKyohei NakadeYasushi ShitanoRena YamazakiHiroshi FujiwaraPublished in: The journal of obstetrics and gynaecology research (2019)
The obstetric outcomes occurring in pregnancies involving HRT use may differ among ET cycles. ET during HRT cycles were associated with adverse obstetric outcomes due to placenta accreta spectrum. The potential interaction between HRT cycles and adverse placental events is novel and warrants further investigation.